Este trabalho teve como objetivo a realização de estudos de Relações Quantitativas Tridimensionais Estrutura-Atividade, QSAR 3D, com identificação de alvos potenciais para compostos 5-nitro-heterocíclicos com estruturas azometínica ou oxadiazolínica com bioatividade dual, antifúngica e anti-T. cruzi, visando à identificação de novos compostos que possam ser aproveitados como possíveis candidatos a fármaco ou como compostos-líderes para novos estudos de modificação molecular. Os compostos estudados pertencem a quatro séries intimamente relacionadas, a saber: Série AzoO: 5-nitro-2-furfurilideno benzidrazidas 4-substituídas; Série AzoS: 5-nitro-2-tiofilideno benzidrazidas 4-substituídas; Série OxaO: 3-acetil-oxadiazolina 2,5-furfurilideno benzidrazidas 4-substituídas e Série OxaS: 3-acetil-oxadiazolina 2,5-tiofilideno benzidrazidas 4-substituídas. A utilização de forma integrada de ferramentas pertencentes às áreas de química farmacêutica, quimioinformática e bioinformática permite a caracterização de cavidades catalíticas de proteínas e a identificação das propriedades físico-químicas consideradas essenciais para a interação adequada entre ligante e biomacromolécula-alvo. Por outro lado, permitem também a identificação de alvos a partir da comparação de estruturas químicas, com as propriedades físico-químicas associadas, entre ligantes conhecidos e possíveis alvos; este procedimento de comparação de perfis moleculares, conhecido como virtual profiling, parte do princípio de que moléculas semelhantes a ligantes conhecidos de proteínas têm o potencial de interagir com essa mesma proteína, onde o grau de semelhança é determinado não somente pela estrutura química, mas também pela distribuição de características físico-químicas. As ferramentas utilizadas em estudos in silico incluem também análise de descritores topológicos que permitem a caracterização de propriedades físico-químicas considerando sua distribuição espacial em relação à estrutura química de uma dada molécula. O uso destes descritores permite a determinação do grau de semelhança entre moléculas ou partes de moléculas (fragmentos moleculares), e encontra-se na base das metodologias de triagem e de caracterização de sítios catalíticos de proteínas. Dentro da proposta de trabalho foram realizados estudos envolvendo virtual profiling, análise de fragmentos moleculares com base em descritores físico-químicos capazes de caracterizar superfícies de proteínas e ligantes, caracterização de cavidade catalítica de possível alvo e docking dos compostos a alvos putativos. Foi também realizada a determinação de atividade antifúngica e análise de resultados de QSAR 3D, levando finalmente à construção de uma hipótese quanto ao possível alvo biológico para os compostos azometínicos e oxadiazolínicos. O procedimento de virtual profiling apontou como possíveis alvos as enzimas CYP19A (aromatase), CYP3A4, CYP3A5 e CYP3A7. Embora estas enzimas não estejam diretamente envolvidas com as atividades biológicas testadas para os compostos até o momento, existem estudos que demonstram a interação de compostos azólicos de ação antifúngica, cujo alvo é CYP51 (14α-desmetilase), também com CYP19A e CYP3A4. Em conjunto com a análise da caracterização das propriedades físico-químicas com uso de descritores topológicos e a própria dualidade da atividade biológica, concluiu-se que seria possível a interação dos compostos das séries estudadas com CYP51, sendo esta enzima alvo não somente de antifúngicos azólicos, como também de compostos com ação anti-T. cruzi. A caracterização da cavidade catalítica de CYP51, tanto em termos de descritores de propriedades físico-químicas como de características estereoquímicas, associada ao estudos de QSAR 3D, confirmaram a possibilidade de interação da série oxadiazolínica com a CYP51, em orientação semelhante à dos antifúngicos azólicos. A série azometínica, que apresenta a mesma atividade dual da série oxadiazolínica, embora com potências diferentes, não possui conformação adequada para a interação da forma proposta. Existem, no entanto, dados que indicam a possibilidade de interação de compostos no sítio catalítico da enzima de forma diferente em relação a compostos oxadiazolínicos e antifúngicos azólicos. / This study had as objective the study of Tridimensional Quantitative Structure-Activity Relationships, 3D QSAR, and the identification of potential targets for 5-nitro-heterocyclic compounds with azomethynic or oxadiazolynic structures presenting dual antifungal and anti-T. cruzi bioactivity, aiming the discovery of new compounds to be used as possible drug candidates or lead compounds. The studied compounds belong to four closely related series: AzoO series: 4-substituted 5-nitro-2-furfurylidene benzhydrazides; AzoS Series: 4-substituted 5-nitro-2-thiophylidene benzhydrazides; OxaO Series: 4-substituted 3-acetyl-oxadiazolyne 2,5-furfurylidene benzhydrazides; and OxaS Series: 4-substituted 3-acetyl-oxadiazolyne 2,5-thiophilydene benzhydrazides. The integrated use of tools belonging to the areas of medicinal chemistry, chemoinformatics, and bioinformatics allow for the characterization of catalytic cavities of proteins and the identification of physicochemical properties considered essential for the adequate interaction between ligand and target biomacromolecule. In addition to this, they also make possible the identification of targets through the comparison of chemical structures, with their associated physicochemical properties, of known ligands and their possible targets; this approach, known as virtual profiling, is based on the principle that molecules similar to known ligands of proteins can potentially interact with this same protein, with the similarity degree being determined not only by chemical structure but also through the distribution of physicochemical characteristics. The tools used in studies in silico also include the analysis of topological descriptors that can be used to analyse physicochemical characteristics considering their spacial distribution in relation to the chemical structure of a given molecule. The use of these descriptors makes possible the determination of the similarity degree between molecules or part of molecules (molecular fragments), and is the basis for methodologies of screening and characterization of the catalytic sites or proteins. Considering the proposed objective, studies were carried involving virtual profiling, analysis of molecular fragments based on physicochemical descriptors able to characterize the surface of ligands and proteins, characterization of the catalytic site of a possible target, and docking of the compounds to putative targets. The antifungal activity of compounds was determined and 3D QSAR results analysed, leading to the formulation of a hypothesis for the possible biological target for the azomethynic and oxadiazolynic compounds. Virtual profiling results pointed as possible targets the P450 enzymes CYP19A (aromatase), CYP3A4, CYP3A5, and CYP3A7. Although these enzymes are not directly involved with the currently tested biological activities for these compounds, there are studies reporting the interaction of azole antifungal compounds, whose target is CYP51 (14α-demethylase), with CYP19A and CYP3A4. Taken together with the analysis of physicochemical characteristics based on topological descriptors, and considering the duality of determined biological activities, it was concluded that the interaction of the studied compounds with CYP51 was possible since this enzyme is the target nor only for azole antifungals, but also for anti-T. cruzi compounds. Characterization studies of CYP51 catalytic cavity considering not only physicochemical properties descriptors but also stereochemical characteristics, associated to the results of 3D QSAR, confirmed the possibility of interaction of compounds from the oxadiazolynic series with CYP51, in an orientation similar to azole antifungals. The azomethynic series, that also presents the same dual biological activity though with different potency, does not present an adequate conformation for the ineraction proposed for the oxadiazolynic series; however, there are reports indicating the possibility of interaction of compounds in the catalytic site of the enzyme in a different way from that of antifungal azoles and the proposed interaction of oxadiazolynic compounds.

O desenvolvimento de radioligantes para o sistema nervoso central (SNC) com características radiotraçadoras que justifiquem seu uso em diagnóstico por geração de imagens é esperado pela comunidade médica nuclear. Os benzodiazepínicos flumazenil-11C e iomazenil-123I são utilizados, com limitações, para investigações clínicas de densidade de sítios receptores benzodiazepínicos no cérebro em patologias como Alzheimer, epilepsia e depressão, entre outras. No Brasil, entretanto, estes traçadores ainda não estão disponíveis para uso clínico. Neste sentido, os flavonóides têm despertado interesses como perspectiva de nova classe de compostos com atividade no SNC podendo originar radiotraçadores com perspectivas para aplicação em imageamento cerebral. Baseado no exposto, a proposta deste estudo envolve o planejamento, a síntese e a marcação com radioiodo (131I e 123I) de flavona e análogos, o controle de qualidade radioquímico, os estudos de biodistribuição e o imageamento, para a avaliação do perfil de captação desses compostos e potencial aplicação em estudos cerebrais, frente a sítios receptores benzodiazepínicos. Os compostos estudados neste trabalho foram obtidos empregando-se a transformação de Baker-Venkataraman. A flavona e análogos foram identificados através de espectros de RMN-1H, RMN-13C e IV. O grau de pureza das substâncias obtidas foi confirmado através da medição da faixa de fusão. Os compostos radiomarcados foram obtidos com alta pureza radioquímica por substituição eletrofílica aromática direta. Esta marcação propiciou estabilidade in vitro após 24 horas e, para a flavona radiomarcada estabilidade in vivo, uma vez que a tireóide não apresentou captação significativa em tempos menores que 1 hora e excreção favorável no tempo de 24 horas. Os estudos de biodistribuição foram realizados em camundongos Swiss, verificando-se alta concentração de flavona-iodo-131 no cérebro, principalmente até 30 minutos após a injeção intravenosa e eliminação favorável após 24 horas de estudo. As imagens cerebrais foram realizadas em coelho New Zeland e em ratos Wistar adquiridas em gama câmara analógica sugerindo que a captação desse ligante no cérebro em tempos curtos, até 30 minutos, viabiliza a aquisição de imagens cintilográficas. Adicionalmente, foram desenvolvidos estudos de modelagem molecular da flavona e da flavona radiomarcada, utilizando-se mecânica quântica AM1 semi-empírico, corroborando a reatividade química desse composto frente à marcação com radioiodo por substituição eletrofílica, processo controlado predominantemente por interações eletrostáticas. Foram calculados os valores individuais de cargas para cada carbono da estrutura da flavona, incluindo cargas de Mulliken, Natural e Eletrostática, e foram gerados os mapas topográficos de distribuição de cargas de ambas as moléculas, evidenciando que as posições 6 e 8, na molécula de flavona, são as mais prováveis para a substituição por radioiodo. / The development of radioligands for the Central Nervous System (CNS) with adequate radiotracer characteristics for the use in imaging diagnostic has been long expected by the medical community. Benzodiazepines flumazenil-11C and iomazenil-123I are employed with limitations in clinical investigations of the density of receptor sites in the brain in pathologies such as Alzheimer, epilepsy, and depression. Nevertheless, in Brazil these radiotracers are not available in market, yet. In this respect, flavonoids has drawing attention as a perspective of a new class of compounds wit CNS activity and potential of originating radiotracers to be employed in brain imaging. Therefore, the goal of this work consisted in the planning, synthesis, and labeling with radioiodine (131I and 123I) of flavone and analogs, as well as to perform radiochemical quality control, biodistribuction, and imaging studies of the radiotracers obtained in order to evaluate the uptake profile and potential for use in cerebral studies of benzodiazepinic receptors sites. To obtain the compounds, we utilized the Baker-Venkataraman transformation, and NMR-1H, NMR-13C, and IR spectroscopy were employed for identification of the molecules. The purity of the compounds obtained was assessed by means of melting point determinations. The radiolabeled compounds were obtained by aromatic electrophilic substitution with a high degree of radiochemical purity. The labeling allowed in vitro stability after 24 hours and in vivo stability of the radiolabeled flavone, provided that the thyroid did not presented significant uptake in less than one hour and favorable excretion in 24 hours. Biodistribution studies were carried out employing Swiss mice. The results indicated high concentrations of flavone-I131 in the brain, especially in the first 30 minutes after intravenous injection, as well as favorable elimination after 24 hours. Brain images were obtained from New Zeland rabbit and Wistar rats in analogical gamma camera, suggesting that short-time brain uptake of the radioligand (up to 30 minutes) allows the acquisition of cynthilographic images. Additionally, molecular modeling studies of the flavone were performed employing the semi-empiric method of AM1. The results corroborate the chemical reactivity of the compound for labeling with radioiodine by aromatic electrophilic substitution, process that is governed mainly by electrostatic interactions. The individual values of Mulliken, Natural, and Electrostatic charges of each carbon atom in flavone structure were calculated and topographic maps of charge distribution were then generated. The analysis of the maps indicates that positions 6 and 8 in the flavone molecule are most likely to present the radioiodine substitution.

Este trabalho teve como objetivo a realização de estudos de Relações Quantitativas Tridimensionais Estrutura-Atividade, QSAR 3D, com identificação de alvos potenciais para compostos 5-nitro-heterocíclicos com estruturas azometínica ou oxadiazolínica com bioatividade dual, antifúngica e anti-T. cruzi, visando à identificação de novos compostos que possam ser aproveitados como possíveis candidatos a fármaco ou como compostos-líderes para novos estudos de modificação molecular. Os compostos estudados pertencem a quatro séries intimamente relacionadas, a saber: Série AzoO: 5-nitro-2-furfurilideno benzidrazidas 4-substituídas; Série AzoS: 5-nitro-2-tiofilideno benzidrazidas 4-substituídas; Série OxaO: 3-acetil-oxadiazolina 2,5-furfurilideno benzidrazidas 4-substituídas e Série OxaS: 3-acetil-oxadiazolina 2,5-tiofilideno benzidrazidas 4-substituídas. A utilização de forma integrada de ferramentas pertencentes às áreas de química farmacêutica, quimioinformática e bioinformática permite a caracterização de cavidades catalíticas de proteínas e a identificação das propriedades físico-químicas consideradas essenciais para a interação adequada entre ligante e biomacromolécula-alvo. Por outro lado, permitem também a identificação de alvos a partir da comparação de estruturas químicas, com as propriedades físico-químicas associadas, entre ligantes conhecidos e possíveis alvos; este procedimento de comparação de perfis moleculares, conhecido como virtual profiling, parte do princípio de que moléculas semelhantes a ligantes conhecidos de proteínas têm o potencial de interagir com essa mesma proteína, onde o grau de semelhança é determinado não somente pela estrutura química, mas também pela distribuição de características físico-químicas. As ferramentas utilizadas em estudos in silico incluem também análise de descritores topológicos que permitem a caracterização de propriedades físico-químicas considerando sua distribuição espacial em relação à estrutura química de uma dada molécula. O uso destes descritores permite a determinação do grau de semelhança entre moléculas ou partes de moléculas (fragmentos moleculares), e encontra-se na base das metodologias de triagem e de caracterização de sítios catalíticos de proteínas. Dentro da proposta de trabalho foram realizados estudos envolvendo virtual profiling, análise de fragmentos moleculares com base em descritores físico-químicos capazes de caracterizar superfícies de proteínas e ligantes, caracterização de cavidade catalítica de possível alvo e docking dos compostos a alvos putativos. Foi também realizada a determinação de atividade antifúngica e análise de resultados de QSAR 3D, levando finalmente à construção de uma hipótese quanto ao possível alvo biológico para os compostos azometínicos e oxadiazolínicos. O procedimento de virtual profiling apontou como possíveis alvos as enzimas CYP19A (aromatase), CYP3A4, CYP3A5 e CYP3A7. Embora estas enzimas não estejam diretamente envolvidas com as atividades biológicas testadas para os compostos até o momento, existem estudos que demonstram a interação de compostos azólicos de ação antifúngica, cujo alvo é CYP51 (14α-desmetilase), também com CYP19A e CYP3A4. Em conjunto com a análise da caracterização das propriedades físico-químicas com uso de descritores topológicos e a própria dualidade da atividade biológica, concluiu-se que seria possível a interação dos compostos das séries estudadas com CYP51, sendo esta enzima alvo não somente de antifúngicos azólicos, como também de compostos com ação anti-T. cruzi. A caracterização da cavidade catalítica de CYP51, tanto em termos de descritores de propriedades físico-químicas como de características estereoquímicas, associada ao estudos de QSAR 3D, confirmaram a possibilidade de interação da série oxadiazolínica com a CYP51, em orientação semelhante à dos antifúngicos azólicos. A série azometínica, que apresenta a mesma atividade dual da série oxadiazolínica, embora com potências diferentes, não possui conformação adequada para a interação da forma proposta. Existem, no entanto, dados que indicam a possibilidade de interação de compostos no sítio catalítico da enzima de forma diferente em relação a compostos oxadiazolínicos e antifúngicos azólicos. / This study had as objective the study of Tridimensional Quantitative Structure-Activity Relationships, 3D QSAR, and the identification of potential targets for 5-nitro-heterocyclic compounds with azomethynic or oxadiazolynic structures presenting dual antifungal and anti-T. cruzi bioactivity, aiming the discovery of new compounds to be used as possible drug candidates or lead compounds. The studied compounds belong to four closely related series: AzoO series: 4-substituted 5-nitro-2-furfurylidene benzhydrazides; AzoS Series: 4-substituted 5-nitro-2-thiophylidene benzhydrazides; OxaO Series: 4-substituted 3-acetyl-oxadiazolyne 2,5-furfurylidene benzhydrazides; and OxaS Series: 4-substituted 3-acetyl-oxadiazolyne 2,5-thiophilydene benzhydrazides. The integrated use of tools belonging to the areas of medicinal chemistry, chemoinformatics, and bioinformatics allow for the characterization of catalytic cavities of proteins and the identification of physicochemical properties considered essential for the adequate interaction between ligand and target biomacromolecule. In addition to this, they also make possible the identification of targets through the comparison of chemical structures, with their associated physicochemical properties, of known ligands and their possible targets; this approach, known as virtual profiling, is based on the principle that molecules similar to known ligands of proteins can potentially interact with this same protein, with the similarity degree being determined not only by chemical structure but also through the distribution of physicochemical characteristics. The tools used in studies in silico also include the analysis of topological descriptors that can be used to analyse physicochemical characteristics considering their spacial distribution in relation to the chemical structure of a given molecule. The use of these descriptors makes possible the determination of the similarity degree between molecules or part of molecules (molecular fragments), and is the basis for methodologies of screening and characterization of the catalytic sites or proteins. Considering the proposed objective, studies were carried involving virtual profiling, analysis of molecular fragments based on physicochemical descriptors able to characterize the surface of ligands and proteins, characterization of the catalytic site of a possible target, and docking of the compounds to putative targets. The antifungal activity of compounds was determined and 3D QSAR results analysed, leading to the formulation of a hypothesis for the possible biological target for the azomethynic and oxadiazolynic compounds. Virtual profiling results pointed as possible targets the P450 enzymes CYP19A (aromatase), CYP3A4, CYP3A5, and CYP3A7. Although these enzymes are not directly involved with the currently tested biological activities for these compounds, there are studies reporting the interaction of azole antifungal compounds, whose target is CYP51 (14α-demethylase), with CYP19A and CYP3A4. Taken together with the analysis of physicochemical characteristics based on topological descriptors, and considering the duality of determined biological activities, it was concluded that the interaction of the studied compounds with CYP51 was possible since this enzyme is the target nor only for azole antifungals, but also for anti-T. cruzi compounds. Characterization studies of CYP51 catalytic cavity considering not only physicochemical properties descriptors but also stereochemical characteristics, associated to the results of 3D QSAR, confirmed the possibility of interaction of compounds from the oxadiazolynic series with CYP51, in an orientation similar to azole antifungals. The azomethynic series, that also presents the same dual biological activity though with different potency, does not present an adequate conformation for the ineraction proposed for the oxadiazolynic series; however, there are reports indicating the possibility of interaction of compounds in the catalytic site of the enzyme in a different way from that of antifungal azoles and the proposed interaction of oxadiazolynic compounds.

L’objectif de ces travaux est de découvrir et de valoriser des petites molécules organiques inhibant l’influx de l’iode dans les cellules thyroïdiennes. Ces composés présentent en effet un double intérêt : à court terme, ils peuvent être dérivés en biosondes afin de mieux caractériser les protéines impliquées dans les mécanismes de transport d’iode par génétique chimique directe. A plus long terme, ces inhibiteurs représentent des candidats-médicaments potentiels pour le traitement de pathologies thyroïdiennes et/ou pour la protection de populations exposées aux radioisotopes de l’iode. Pour chacune des deux familles d’inhibiteurs considérées, nous avons donc tout d’abord synthétisé une chimiothèque d’une centaine d’analogues ; puis ces derniers ont été évalués biologiquement afin de fournir un ensemble de relations structure-activité. Par ailleurs, la configuration absolue des centres stéréogènes nécessaire à l’activité biologique a été déterminée : dans chacun des cas, une stéréochimie particulière est responsable du pouvoir inhibiteur des composés. A partir de ces informations, une dizaine d’analogues « de seconde génération » a été synthétisée dans chaque famille, en combinant plusieurs modifications structurales contribuant à l’activité biologique. Après évaluation biologique, neuf d’entre eux possèdent des IC50 < 6 nM et des propriétés physico-chimiques satisfaisantes pour des candidats-médicaments. Enfin, dans chaque famille, une biosonde photoactivable biotinylée a été synthétisée et utilisée en photomarquage d’affinité. Plusieurs protéines marquées spécifiquement ont été repérées, qui correspondraient à des protéines-cibles de chacun des inhibiteurs et dont l’identification reste à achever. / This work was intended to discover small organic molecules acting as iodide uptake inhibitors in thyroid cells. These compounds can indeed be derivatized into biochemical probes for further characterization of proteins involved in iodide transport mechanisms. On the long term, these inhibitors also appear as attractive drug candidates for treatment of thyroid pathologies or radioprotection against iodine isotopes. A similar strategy was adopted for both of the two inhibitor families. First, we synthesized a chemical library of around 100 analogues; we measured their IC50 against iodide uptake in FRTL-5 cells to get structure-activity relationships. Absolute configuration of stereogenic centers was also investigated, and a preferential stereochemistry was found to be responsible for activity. From this basis, around twenty « second-generation » analogues were synthesized by combining fragments contributing to biological activity. Biological evaluation indicated that nine were very potent inhibitors, with IC50 < 6 nM and satisfying physicochemical properties required for drug candidates. Finally, one photoactivatable biotinylated probe was developed in each family and used for photoaffinity labeling. Several specifically labeled proteins are still under identification and constitute new potential therapeutic targets.

Ce projet de recherche se focalise sur les infections par mycobacterium ulcerans (maladie de l’ulcère de Buruli), une maladie de la peau dévastatrice caractérisée par la formation de lésions nécrotiques progressives et l’absence d’une réponse inflammatoire. Bien que négligée, cette infection est la troisième maladie mycobactérienne la plus répandue après la tuberculose et la lèpre et des cas sont rapportés dans plus de 30 pays à travers le monde. Mycobacterium ulcerans sécrète une toxine polycétidique complexe, appelée mycolactone A/B, qui est directement responsable des effets pathogènes de la maladie. Depuis sa découverte, les propriétés biologiques inhabituelles de la mycolactone A/B ont suscité de nombreux efforts de recherche dans différents domaines. Dans ce contexte, ce projet s’intéresse à l’élucidation du mécanisme d’action des mycolactones en utilisant la synthèse totale comme outil principal. Dans cette optique, notre équipe a mis en place une voie de synthèse permettant un accès facile et robuste à différents mimes de mycolactone. L’utilisation de cette méthode a conduit à la préparation de 13 mimes de la toxine au cours de cette thèse. D’autre part notre équipe s’intéresse également à la préparation de mimes possédant un ou plusieurs atomes de fluor. Ces derniers présentent un intérêt particulier pour améliorer la compréhension des interactions ayant lieu entre la toxine et sa cible cellulaire. Les travaux réalisés autours de la synthèse de mycolactones fluorés ont conduit à la mise au point d’une méthode générale et simple pour introduire un groupe trifluorométhyle sur un alcyne terminal, permettant ainsi des modulations inédites de la structure de la toxine. / This research project focuses on mycobacterium ulcerans infection (Buruli ulcer disease), a severe skin disease characterized by the formation of progressive necrotic lesions and the lack of an acute inflammatory response. Although neglected, this infection is the third most common mycobacteriosis after Mycobacterium tuberculosis and Mycobacterium leprae, and cases are reported in more than 30 countries worldwide. Mycobacterium ulcerans secretes a complex polyketidic macrolide, called mycolactone A/B, which is directly involved in the biological effects of the disease. Since its discovery, the unusual biology triggered by this toxin has spurred research efforts. In this context, this research project aims at a better understanding of mycolactone A/B molecular interactions by using total synthesis as main tool. To this end, our research team has developed an efficient synthetic pathway allowing the preparation of different mimetics of the toxin. This synthesis has been used to prepare thirteen new mycolactone mimetics during this thesis. Moreover our team has also been interested in the synthesis of fluorinated mycolactone analogs. Such fluorinated mycolactones are of great interest to improve the interactions that occur between the toxin and its biological binding site. Work in this field led to the development of a simple and general method to introduce a trifluoromethyl group onto a terminal alkyne, allowing novel modulation of the structure of the toxin.

Una de les àrees més prometedores en recerca biomèdica i farmacèutica és el disseny molecular computacional, que intenta establir relacions entre propietats físico-químiques i activitat biològica. L'èxit d'aquestes tècniques depen críticament de la qualitat de la descripció molecular. En aquest sentit, metodologies basades en potencials d'interacció molecular (MIP) són eines útils per la comparació de compostos que presenten comportaments biològics semblants. Aquest projecte desenvolupa eines per comparar molècules basades en la caracterització de llurs MIPs. El programa de similaritat molecular MIPsim ha estat desenvolupat i aplicat a diferents problemes biològics. Aquesta tesi consisteix en quatre estudis científics que mostren l'ús del MIPSim en aliniament molecular, catalisi enzimàtica, en acoratge de molècules dins el lligand i en estudis 3D-QSAR. / One of the most promising areas in biomedical and pharmaceutical research is computer assisted molecular design, which tries to stablish relationships between physicochemical properties and biological activity. The success of these techniques depends critically on the quality of the molecular description. In this sense, methodologies based on molecular interaction potentials (MIP) are useful tools for the comparison of compounds displaying related biological behaviours. This project aims to develop tools to compare 'molecules based on the characterization 'of their MIPs. To this end, the molecular similarity program MIPSim has been further developed and applied to different biological problems. This thesis consists on four scientific studies showing the use of MIPSim for molecular alignment, enzymatic catalysis, ligand-protein docking and 3D-QSAR analyses.

Chapter 1 gives background information on proteases and discusses the concept of protease inhibition as a therapeutic strategy for humans. It introduces the key concept that conformation defines biological activity. It also outlines how proteases almost universally bind their substrate/inhibitors in an extended β-strand conformation. The use of calpain as a prototype protease for the testing of β-strand mimics synthesised later in the thesis is also discussed. Chapter 2 describes how molecular modeling was used to rationalise the structure based activity relationships (SAR) of known calpain inhibitors. Molecular modeling was then used to successfully design a number of acyclic β-strand mimics. The synthesis and testing of eight such inhibitors is described. The most potent β-strand mimic prepared was 2.13. This was determined to have an IC₅₀ of 30 nM against calpain II. Chapter 3 outlines the history and application of ring closing metathesis (RCM) to the synthesis of cyclic compounds. The attempted synthesis of an eight membered cyclic nitrogen to nitrogen conformationally constrained dipeptide is described. The synthesis of a conformationally constrained β-amino acid calpain inhibitor (3.73) is also described. A novel calpain inhibitor motif was designed in Chapter 4. On the basis of this an in-silico combinatorial library of two hundred and eighty eight possible β-strand templates was prepared. Conformational analysis of this library was performed and from this a number of excellent β-strand templates were identified and selected for synthesis. The preparation of ten β-strand templates is described. New microwave irradiation methodology was developed to achieve this. vii The formation of a six-membered catalyst deactivating chelate is also proposed to explain why some dienes fail to undergo RCM. Two methods to circumvent the formation of such a chelate are outlined. The addition of Lewis acid chloro-dicyclohexyl borane to the RCM reaction mixture and chain length alteration are investigated. Chapter 5 describes the design of macrocyclic β-strand mimics using induced fit molecular modelling. The physicochemical properties of these were calculated in-silico. From this analysis a number of Tyr-XX-Gly based and Tyr-XX-Cys based macrocyclic calpain inhibitors were selected for synthesis. The preparation and testing of these are described. In the Tyr-XX-Gly macrocyclic system a number of variables were investigated and numerous SAR implications concluded. Aldehyde 5.14 was identified as the best electrophilic warhead macrocyclic calpain inhibitor with an IC₅₀ against calpain II of 27 nM. The best non-electrophilic warhead macrocycle (5.13) had an IC₅₀ against calpain II of 704 nM. Chapter 6 describes synthetic optimisation for the preparation of calpain inhibitors 2.13, 5.14 and 5.17. Multi-gram quantities of each were prepared. Aldehydes 2.13 and 5.14 were evaluated as anti-cataract agents using in-vivo cataract sheep model. Both of these β-strand mimics were demonstrated to retard cataract development. Macrocycle 5.14 was found to be the most effective, decreasing the rate of cataract development between forty four and forty nine per cent relative to control. Chapter 7 outlines the attempted development of RCM methodology for the chiral synthesis of α-α disubstituted amino acid lactams. In addition, methodology for the stereoselective incorporation of a C-N constrained β-amino acid carbocycle into a peptide or peptidomimetic is described.

L'ulcère de Buruli est une maladie nécrosante de la peau et des tissus mous accompagnée d'ulcères de grandes tailles, causée par une mycobactérie. L’Organisation Mondiale de la Santé a lancé en 1998 une initiative mondiale contre cette maladie tropicale négligée, présente notamment en Afrique et en Australie. L'infection est causée par Mycobacterium ulcerans, mycobactérie faisant partie de la même famille que les mycobactéries responsables de la tuberculose et de la lèpre. Mycobacterium ulcerans sécrète une toxine nommée mycolactone, responsable de cette infection. Cette toxine a des propriétés cytotoxiques et immunosuppressives. Le projet de recherche développé dans l'équipe concerne la synthèse et l'évaluation biologique des mycolactones A et B et de leurs analogues. A l'heure actuelle, la première étude relation structure-activité conduisant à une meilleure compréhension du mode d'action des mycolactones a été établie. La stratégie de synthèse choisie implique plusieurs réactions de couplage catalysées par des métaux (fer, cuivre, palladium) pour la création de liaisons carbone-carbone. La stéréochimie des sept alcools secondaires a quant à elle été contrôlée par des réactions d'allyl-et crotylboration asymétrique ainsi que par des réactions de dihydroxylation catalytique et asymétrique. Au cours de ce travail de thèse, 12 analogues ont ainsi été obtenus en appliquant cette voie de synthèse. / Buruli ulcer, a severe necrotizing skin disease caused by Mycobacterium ulcerans, is one of the most neglected tropical diseases. The World Health Organization has started in 1998 a Global Initiative against this disease. The pathogen belongs to the same family as the mycobacteria responsible for tuberculosis and leprosy and 6000 new cases are registered each year. Infection leads to extensive destruction of the skin and soft tissues with the formation of large ulcers usually on the legs or the arms and can caver up 15% of the skin surface. These effects are due to the presence of the bacterial toxins mycolactones, secreted by M ulcerans. Mycolactones are the first polyketides isolated from a human pathogen. Deciphering their functional interactions is of fundamental importance for the understanding and ultimately the control of this devastating mycobacterial infection. A Diverted Total Synthesis approach of mycolactones analogues has been developed and provides the first insights into their structure-activity relationship based on cytopathic assays on L929 fibroblasts.

No description available.

Le traitement et le diagnostic de maladies d'origine génétique suscite un grand intérêt à l'heure actuelle. De par leur spécificité d'appariement avec les acides nucléiques, les oligonucléotides possèdent un grand potentiel dans ce domaine. Ils se heurtent toutefois à des limitations majeures, dont leur faible stabilité en milieu physiologique et la difficulté qu'ils ont à franchir les membranes biologiques. De nombreuses équipes de recherche s'intéressent, afin de pallier ces limitations, à la conception et à la synthèse d'oligonucléotides chimiquement modifiés. Parmi ceux-ci, les Locked Nucleic Acids (LNA), présentant une modification qui consiste en l'insertion d'un pont −O−CH2− entre l'atome C2' et l'atome C4' du sucre, constituent une famille qui semble posséder les propriétés requises. Ils sont considérés comme des candidats très prometteurs en tant qu’agents thérapeutiques et qu’outils de diagnostic du génome. La caractérisation de la stabilité et de la sélectivité d'appariement entre les LNA et les acides nucléiques naturels est, dans ce contexte, important.<p><p>Dans ce travail, nous avons étudié la stabilité, la sélectivité d'appariement ainsi que la dynamique de la structure double brin d'un oligonucléotide hybride LNA-DNA, et nous avons comparé ces propriétés à celles d'un oligonucléotide DNA-DNA de même séquence. Ce dernier est constitué de 11 paires de bases formées par l'appariement du brin 5'-GCGTGTGTGCG-3' avec le brin 3'-CGCACACACGC-5'. Dans le cas de l'hybride, les nucléotides du second brin sont tous remplacés par des LNA.<p><p>La stabilité a été étudiée expérimentalement par différentes techniques :spectroscopie d'absorption UV, calorimétrie différentielle à balayage, résonance magnétique nucléaire et calorimétrie à titrage isotherme. Ces études montrent que la stabilité du duplexe hybride est plus importante que celle du naturel, et que ce phénomène s'explique par un terme entropique plus favorable pour la formation du duplexe LNA-DNA que pour la formation du duplexe DNA-DNA.<p><p>La sélectivité d'appariement a été étudiée en comparant la stabilité des deux oligonucléotides étudiés avec celle d'oligonucléotides présentant un mésappariement dans la séquence. Nos résultats montrent que la sélectivité d'appariement du brin LNA n'est pas significativement différente de celle du brin DNA. Ce résultat ne doit cependant pas être généralisé car nous n'avons testé qu'une position centrale pour le mésappariement.<p><p>L'étude de la dynamique de la structure des oligonucléotides a été effectuée par RMN et porte sur la caractérisation de la cinétique de l'ouverture individuelle des paires de bases. Nous observons que la durée de vie de l'état fermé des paires de bases G-C est supérieure dans l'oligonucléotide LNA-DNA, tandis que l'état fermé des paires A-T semble posséder une durée de vie supérieure dans l'oligonucléotide DNA-DNA.<p><p>Au cours de ce travail de thèse nous avons pu caractériser les facteurs énergétiques à la base de la stabilité accrue des oligonucléotides chimiquement modifiés de type LNA. Nous avons montré que leur sélectivité d’appariement n’est pas toujours supérieure à celle des oligonucléotides naturels et dépend des séquences impliquées. Enfin, nous avons mis en évidence les différences entre la dynamique de la structure d’un oligonucléotide possédant des LNA et celle d’un duplexe DNA. / Doctorat en Sciences de l'ingénieur / info:eu-repo/semantics/nonPublished